WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) expressed serious concern with the Medical Innovation Act introduced by Senator Elizabeth Warren (D-MA). The legislation proposes to increase funding for the National Institutes of Health (NIH) by creating a new statutory scheme that would impose a fee on biopharmaceutical companies working on critical treatments and cures for patients.
The following can be attributed to Jim Greenwood, President and CEO of BIO:
Help employers find you! Check out all the jobs and post your resume.
